[1]
N. Rubini, L. Ensina, E. Silva, F. Sano, and D. Solé, “Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis”, Allergol Immunopathol, vol. 47, no. 6, pp. 515–522, Dec. 2019, Accessed: Sep. 10, 2025. [Online]. Available: https://all-imm.com/index.php/aei/article/view/264